This inventor holds 7 USPTO granted patents and 2 EPO patents. Top assignee: Astellas Pharma Gmbh. Active years: 2007-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tsukuba, JP (2007)
- Chuo-ku, JP (2009 - 2010)
- Tokyo, JP (2010 - 2013)
Company Filing History:
Years Active: 2007-2025
Title: The Innovations of Masakatsu Kawakami: Advancements in Cancer Treatment and Ulcer Therapy
Introduction
Masakatsu Kawakami, based in Tokyo, Japan, is a prominent inventor in the field of biopharmaceuticals. With a remarkable portfolio of 7 patents, Kawakami has made significant contributions to medical treatments, particularly in cancer therapy and gastrointestinal ailments. His latest innovations demonstrate a commitment to addressing urgent health challenges.
Latest Patents
One of Kawakami's notable recent patents is an anti-human Fn14 antibody designed to bind to human Fn14 to inhibit its action, thereby aiding in the prevention or treatment of cancer cachexia. This innovative antibody comprises a heavy chain with a specific amino acid sequence (SEQ ID NO: 2) and a light chain that follows the sequence (SEQ ID NO: 4). Furthermore, he has contributed to the development of a treatment for stomach or small intestine ulcers using 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic acid, demonstrating its effectiveness in healing such ulcers.
Career Highlights
Kawakami's career is notably associated with Astellas Pharma GmbH, where he collaborates on groundbreaking research and development projects. His innovative spirit and dedication to medical science have been pivotal in advancing the company's therapeutic objectives.
Collaborations
Throughout his career, Kawakami has worked alongside esteemed colleagues, including Junji Sato and Yoshihiro Keto. Their collaborations have fostered a fertile environment for innovation, leading to the development of effective pharmaceutical solutions that address pressing health concerns.
Conclusion
Masakatsu Kawakami's contributions to science and medicine highlight the importance of innovation in the pharmaceutical industry. With his extensive patent portfolio and collaborative projects, he continues to pave the way for new treatments that improve patient outcomes and enhance the quality of life for many. His work exemplifies the impact that dedicated inventors can have in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile